A federal court in Philadelphia has emphatically rejected a broad attempt by the U.S. Department of Justice (DOJ) to access sensitive medical records related to gender-affirming care. This ruling serves to protect the privacy of minors receiving essential healthcare at the Children's Hospital of Philadelphia.
On Friday, U.S. District Judge Mark A. Kearney for the Eastern District of Pennsylvania issued an order quashing subpoenas that sought extensive personal and clinical data. The demands included names, dates of birth, Social Security numbers, home addresses, and detailed clinical notes for minors who have received treatment since January 2020. The court's decision underscored that the government "lacks statutory authority for a rambling exploration of the Hospital’s files to learn the names and medical treatment of children."
The subpoenas, originally issued by the Trump administration in July, were pursued under allegations of fraud in gender-affirming care. As Advocate reports, Families in Pennsylvania had subsequently filed motions to quash these demands, which required an exhaustive range of documentation, such as "intake forms, consent paperwork, and parental authorizations for puberty blockers and hormone therapy."
Judge Kearney's ruling unequivocally stated that the medical records in question concern lawful treatment governed by Pennsylvania law. It explicitly found that the constitutional privacy interests of children and their families "far outweigh" the government’s asserted investigative needs. The court also critically noted the DOJ's shifting justifications for its actions, observing that the government had "replaced" its initial rationale at one point and issued a reminder that "false statements may be subject to a perjury investigation."
This judicial affirmation arrives amid a broader, concerted effort by the Trump administration against gender-affirming care, which saw more than 20 subpoenas dispatched to clinics and hospitals across various states in July. Leading professional medical organizations, including the American Medical Association, have consistently affirmed gender-affirming treatments as evidence-based and life-saving, emphasizing their critical role in patient well-being.
Advocates and legal counsel praised the decision as a vital stand against governmental overreach. Mimi McKenzie of the Public Interest Law Center remarked in a press release, “This is a critical win for everyone who believes healthcare decisions should be made in doctors’ offices, not the White House.” Attorney Jill Steinberg of the law firm Ballard Spahr added that the ruling delivers a powerful message to transgender youth and their families, assuring them that "you do not have to fight these battles alone."